Guerbet 9M revenue falls 2.2% to €573.8M; 2026 targets reiterated
Guerbet reported nine-month 2026 revenue of €573.8M, down 2.2%, and kept all of its 2026 financial targets unchanged. Figures per GlobeNewswire.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Guerbet said revenue for the first nine months of 2026 reached €573.8 million. It fell 2.2% as reported and 1.3% at constant exchange rates, while the third quarter declined 3.6% at constant rates. The details come from a press release distributed by GlobeNewswire.
The company reiterated all of its 2026 financial targets. Excluding China, it said revenue would have grown 1%. Interventional Radiology sales rose 6.6% over the nine months.
why it matters
The main pressure comes from China and currency effects, which weighed more heavily on the first half. Keeping guidance limits concerns about a target cut, but the softer third quarter leaves open questions about momentum in the second half of the year.
market impact
Guerbet (GBT): weak China sales and currency effects weigh on revenue; kept targets limit downside risk
tags
instruments
sources
- Guerbet (GBT) 9M Revenue €573.8M, Down 2.2%; 2026 Targets Reiterated — globenewswire.com, 22 October 2026 at 15:45 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗